| Michael W Potter, MD | |
|
123 Summer St, Suite 210, Worcester, MA 01608-1312 | |
| (508) 368-3190 | |
| (508) 368-3985 |
| Full Name | Michael W Potter |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 27 Years |
| Location | 123 Summer St, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124004403 | NPI | - | NPPES |
| 04 2472266 | Other | PRIVATE HEALTHCARE SYST. | |
| 2023718 | Other | CIGNA HEALTH PLAN | |
| 3208125 | Other | MEDICAID WELFARE | |
| 7985198 | Other | AETNA US HEALTHCARE | |
| 04 2472266 | Other | ONE HEALTH PLAN | |
| 2230931 | Other | FIRST HEALTH | |
| 70438 | Other | CHILDRENS MEDICAL | |
| AA16160 | Other | HARVARD PILGRIM HEALTH | |
| J22264 | Other | BLUE SHIELD HMO BLUE | |
| 784068 | Other | MVP HEALTH CARE | |
| 04 2472266 | Other | THREE RIVERS | |
| 419312 | Other | TUFTS HEALTH PLAN | |
| 60679 | Other | FALLON COMMUNITY HEALTH | |
| A37468 | Other | MEDICARE B | |
| J22264 | Other | BLUE CARE ELECT | |
| 3208125 | Medicaid | MA | |
| 70438 | Other | HEALTHY START | |
| 784069 | Other | MVP HEALTH CARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 160784 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent Hospital | Worcester, MA | Hospital |
| Umass Memorial Medical Center/university Campus | Worcester, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reliant Medical Group Inc | 5597755322 | 543 |
News Archive
Occupational contact dermatitis and asthma are two of the most common work-related health issues facing workers worldwide, according to experts presenting the latest research at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.
Ebola could be already on the prowl in Tanzania, but the government is keeping it a secret. This is the official position of the World Health Organization (WHO), who says multiple cases have been secretly reported to it.
Eleven Biotherapeutics, a biopharmaceutical company focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics, announced today it has completed a $35 million Series A financing co-led by Flagship Ventures and Third Rock Ventures. Proceeds from the financing will be used to build the research and development and business development teams for Eleven Biotherapeutics, in addition to advancing the company's portfolio of engineered proteins through clinical proof of concept.
According to the Obama administration's 2014 budget document, the federal government will spend about $4 billion on federal- and state-run marketplaces for individual and small businesses purchasing insurance coverage.
This past summer saw a revolution in melanoma therapy. Patients whose melanoma lesions contain a mutation in the BRAF gene were successfully treated with a BRAF-specific inhibitor, PLX4032. Reports of the drug trial described shrinking tumors and improved health. Yet seven months after therapy began the tumors returned and resumed growing. Now, scientists at The Wistar Institute explain why: the tumor learns to signal around the blocked gene by adjusting its molecular wiring.
› Verified 5 days ago
| Entity Name | Reliant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720017528 PECOS PAC ID: 5597755322 Enrollment ID: O20040708000650 |
News Archive
Occupational contact dermatitis and asthma are two of the most common work-related health issues facing workers worldwide, according to experts presenting the latest research at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.
Ebola could be already on the prowl in Tanzania, but the government is keeping it a secret. This is the official position of the World Health Organization (WHO), who says multiple cases have been secretly reported to it.
Eleven Biotherapeutics, a biopharmaceutical company focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics, announced today it has completed a $35 million Series A financing co-led by Flagship Ventures and Third Rock Ventures. Proceeds from the financing will be used to build the research and development and business development teams for Eleven Biotherapeutics, in addition to advancing the company's portfolio of engineered proteins through clinical proof of concept.
According to the Obama administration's 2014 budget document, the federal government will spend about $4 billion on federal- and state-run marketplaces for individual and small businesses purchasing insurance coverage.
This past summer saw a revolution in melanoma therapy. Patients whose melanoma lesions contain a mutation in the BRAF gene were successfully treated with a BRAF-specific inhibitor, PLX4032. Reports of the drug trial described shrinking tumors and improved health. Yet seven months after therapy began the tumors returned and resumed growing. Now, scientists at The Wistar Institute explain why: the tumor learns to signal around the blocked gene by adjusting its molecular wiring.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael W Potter, MD 630 Plantation St, Worcester, MA 01605-2038 Ph: (508) 368-3190 | Michael W Potter, MD 123 Summer St, Suite 210, Worcester, MA 01608-1312 Ph: (508) 368-3190 |
News Archive
Occupational contact dermatitis and asthma are two of the most common work-related health issues facing workers worldwide, according to experts presenting the latest research at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.
Ebola could be already on the prowl in Tanzania, but the government is keeping it a secret. This is the official position of the World Health Organization (WHO), who says multiple cases have been secretly reported to it.
Eleven Biotherapeutics, a biopharmaceutical company focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics, announced today it has completed a $35 million Series A financing co-led by Flagship Ventures and Third Rock Ventures. Proceeds from the financing will be used to build the research and development and business development teams for Eleven Biotherapeutics, in addition to advancing the company's portfolio of engineered proteins through clinical proof of concept.
According to the Obama administration's 2014 budget document, the federal government will spend about $4 billion on federal- and state-run marketplaces for individual and small businesses purchasing insurance coverage.
This past summer saw a revolution in melanoma therapy. Patients whose melanoma lesions contain a mutation in the BRAF gene were successfully treated with a BRAF-specific inhibitor, PLX4032. Reports of the drug trial described shrinking tumors and improved health. Yet seven months after therapy began the tumors returned and resumed growing. Now, scientists at The Wistar Institute explain why: the tumor learns to signal around the blocked gene by adjusting its molecular wiring.
› Verified 5 days ago
Elizabeth A Mahanor, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-368-3190 Fax: 508-368-3193 | |
Dr. Craig A Paterson, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 119 Belmont St, Department Of General Surgery, Worcester, MA 01605 Phone: 508-334-8195 | |
Dr. John M Castle, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 281 Lincoln St, Department Of Surgery, Worcester, MA 01605 Phone: 508-334-5958 Fax: 508-334-5752 | |
Frank Traupman, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 281 Lincoln St, Medical Staff Svcs, Worcester, MA 01605 Phone: 508-334-8015 | |
Philip A Cohen, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Department Of Surgery, Worcester, MA 01655 Phone: 508-856-7559 Fax: 508-856-4224 | |
Mary Elise Huerter, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-3278 Fax: 508-334-7284 | |
Jennifer Fantasia, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 33 Kendall St, Worcester, MA 01605 Phone: 083-348-7655 Fax: 508-334-9477 |